Obsessive-Compulsive Disorder (OCD)

What Healing TMS Clinic offers for OCD: Deep TMS using the BrainsWay system (FDA cleared for OCD in 2018) as the primary in-house treatment, plus SSRI medication management. Patients seeking exposure and response prevention (ERP) psychotherapy — the standard CBT modality for OCD — are referred to specialty OCD therapists.

Obsessive-compulsive disorder is a neuropsychiatric condition characterized by intrusive, unwanted obsessions and repetitive compulsions performed to neutralize anxiety or prevent feared outcomes.¹ The DSM-5-TR classifies OCD within the Obsessive-Compulsive and Related Disorders chapter, reflecting evidence that OCD is mechanistically distinct from the anxiety disorders and involves hyperactivity of the cortico-striato-thalamo-cortical (CSTC) loop. Lifetime prevalence in U.S. adults is approximately 2.3%, with twelve-month prevalence near 1.2%.² Median age of onset is 19, and roughly one-quarter of cases begin before age 14. OCD is diagnosed by structured clinical interview against DSM-5-TR criteria.

Recognized signs and symptoms

Obsessions

• Recurrent, persistent, intrusive thoughts, images, or urges experienced as unwanted (egodystonic)
• Common content: contamination, harm to self or others, symmetry/order, taboo sexual or religious themes
• Attempts to ignore or suppress them, or to neutralize with another thought or action

Compulsions

• Repetitive behaviors (handwashing, checking, ordering) or mental acts (counting, praying, repeating words silently)
• Performed in response to an obsession or according to rigid rules
• Aimed at reducing distress or preventing a feared event — not connected in a realistic way to what they aim to prevent, or clearly excessive

Functional features

• Time-consuming (>1 hour/day) or clinically significant distress
• Avoidance of triggering situations
• Frequent comorbidity with depression, anxiety, tic disorders, and ADHD

Diagnostic criteria

DSM-5-TR criteria require the presence of obsessions, compulsions, or both; symptoms that are time-consuming or cause clinically significant distress or impairment; and exclusion of substance and other medical etiologies.¹ Severity is most commonly measured with the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), a clinician-administered instrument that grades obsession and compulsion severity from subclinical to extreme. Y-BOCS scores ≥16 typically indicate moderate-to-severe illness and define the candidacy threshold in much of the TMS literature.³ Diagnosis is established by a qualified clinician; this page is educational and not a tool for self-diagnosis.

Treatment options at Healing TMS Clinic

Evidence-based first-line treatment for OCD combines exposure and response prevention (ERP) — the gold-standard psychotherapy — with a serotonergic antidepressant at therapeutic OCD-range dose.

• Exposure and response prevention (ERP) — the most extensively validated psychotherapy for OCD, with effect sizes superior to medication alone in many trials.³ Referred through our vetted clinician network.
• Medication management — SSRIs (fluoxetine, sertraline, paroxetine, fluvoxamine, escitalopram) at OCD-range doses (often higher than depression dosing) and clomipramine as a second-line tricyclic option. Antipsychotic augmentation (aripiprazole, risperidone) is considered for partial response.
• TMS Therapy — deep TMS is FDA-cleared for OCD as adjunctive treatment in adults.⁴ Availability depends on the device used at the clinic; ask during your consultation.

When to consider TMS Therapy

Where the appropriate device is available, deep TMS for OCD is FDA-cleared as adjunctive treatment in adults.⁴ It is appropriate to consider when:

• The patient has had an inadequate response to first-line treatment — typically a therapeutic-dose SSRI trial and an adequate course of ERP
• Y-BOCS score reflects at least moderate severity (often ≥20 in pivotal trials)
• No personal history of seizure disorder and no ferromagnetic implants near the treatment coil
• The patient is medically stable for an outpatient course

The OCD protocol differs from the depression protocol: it targets the medial prefrontal cortex / anterior cingulate cortex, sessions are typically preceded by brief symptom-provocation, and the standard course is approximately 29 daily sessions over six weeks. See TMS Therapy for full mechanism, protocol, and safety detail.

Insurance and TMS for OCD

Insurance coverage for TMS in OCD is narrower than for depression but has expanded since the 2018 FDA clearance. Some commercial carriers cover deep TMS for OCD when standard criteria are met — typically documented failure of at least one therapeutic-dose SSRI trial and an adequate ERP course, and a Y-BOCS consistent with moderate-to-severe illness. Medicare coverage for TMS in OCD varies by region and Medicare Administrative Contractor.

Prior authorization is required by most carriers and timelines vary. Our team verifies benefits and handles authorization paperwork. Submit your insurance details through our verification form and we will confirm OCD-specific TMS coverage and expected cost.

What to expect at your consultation

The initial visit is a structured diagnostic evaluation including Y-BOCS administration, review of prior SSRI and ERP trials, and screening for TMS candidacy. We serve patients across Anaheim and Orange County. Schedule a consultation to begin.

References